Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil

Table 3 Pathological findings

	PET-CMR, n = 22	Non-PET-CMR, n = 36	P value
T
T0	9	5	< 0.0001
T1	11	4
T2	1	9
T3	1	12
T4	0	6
N
N0	13	14	0.052
N1	7	7
N2	2	8
N3	0	7
M
M0	20	32	0.81
M1	2	4
Stage
0	9	3	0.033
I	3	8
II	8	8
III	0	10
IVA	2	4
IVB	0	3
Ly+	4	22	0.001
v+	1	15	0.002
Pathological grade
0	0 (0%)	3 (8%)	0.029
1a	4 (18%)	14 (39%)
1b	3 (14%)	6 (17%)
2	6 (27%)	10 (28%)
3	9 (41%)	3 (8%)

Ly: Lymphatic invasion; PET-CMR: Positron emission tomography-complete metabolic response; v: Venous invasion.